
Chinese drugmakers weigh options as US mulls pharma tariffs
Tariffs are back in play. On April 9, US President Donald Trump announced plans to slap new tariffs on pharmaceuticals, urging drugmakers to shift production back to US soil. The rationale? The size of the US market justifies manufacturing at home. The …